| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LianBio | Director | Ordinary Shares | 17,082 | $81,310 | $4.76 | 15 Feb 2024 | Direct |
| Lyra Therapeutics, Inc. | Director | Stock Option | 30,000 | 13 Jun 2024 | Direct | ||
| LianBio | Director | Stock Option (Right to Buy) | 0 | 15 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARYD | ARYA Sciences Acquisition Corp IV | 31 Jul 2024 | 0 | $0 | 4 | Chief Business Officer | 31 Jul 2024, 21:45 |
| LYRA | Lyra Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:10 |
| LIAN | LianBio | 15 Feb 2024 | 3 | -$1.68 | 4 | Director | 20 Feb 2024, 17:27 |
| LYRA | Lyra Therapeutics, Inc. | 30 Jun 2023 | 1 | $0 | 4 | Director | 05 Jul 2023, 21:50 |
| LIAN | LianBio | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:10 |
| LIAN | LianBio | 23 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 17:37 |
| LYRA | Lyra Therapeutics, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 16:06 |
| LIAN | LianBio | 29 Oct 2021 | 0 | $0 | 3 | Director | 29 Oct 2021, 18:36 |
| ARYE | ARYA Sciences Acquisition Corp V | 12 Jul 2021 | 0 | $0 | 3 | Chief Business Officer | 12 Jul 2021, 19:50 |
| LYRA | Lyra Therapeutics, Inc. | 26 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 18:25 |